Schrödinger To Present New Preclinical Data From Its Wee1 Inhibitor Program At AACR Annual Meeting 2022Business Wire • 03/08/22
Schrödinger to Present at Truist Securities Life Sciences AI Symposium - Biotech & ToolsBusiness Wire • 02/28/22
Schrodinger, Inc. (SDGR) CEO Ramy Farid on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/25/22
Schrödinger Reports Financial Results for the Fourth Quarter and Full Year 2021Business Wire • 02/24/22
Analysts Estimate Schrodinger, Inc. (SDGR) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 02/17/22
Schrödinger to Announce Fourth Quarter and Full-Year 2021 Financial Results on February 24Business Wire • 02/10/22
Schrödinger to Present at SVB Leerink Virtual 11th Annual Global Healthcare ConferenceBusiness Wire • 02/08/22
Schrödinger: Conviction Remains High, Q4 Report And Guidance Will Be CriticalSeeking Alpha • 01/06/22
Schrödinger Reports Preclinical Data Supporting Advancement Of Its MALT1 Inhibitor Program At American Society Of Hematology 2021 Annual MeetingBusiness Wire • 12/11/21
Schrödinger, Inc.'s (SDGR) CEO Ramy Farid on Q3 2021 Results - Earnings Call TranscriptSeeking Alpha • 11/11/21
Schrodinger, Inc. (SDGR) Reports Q3 Loss, Misses Revenue EstimatesZacks Investment Research • 11/11/21
Schrödinger Reports Third Quarter 2021 Financial Results and Provides Company UpdateBusiness Wire • 11/10/21